Institution statistics

CELGENE MANAGEMENT SARL - CH 

Ranking results:

Past rankings:
2018
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 0 8.713.395 0 1
2018 0 14.105.750 0 1
2017 0 23.749.833 0 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
JANSSEN PHARMACEUTICA NV3
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE3
NOVARTIS PHARMA3
ABBVIE INC2
AMGEN2
BAYER AKTIENGESELLSCHAFT2
ELI LILLY AND COMPANY LIMITED2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER2
PFIZER LIMITED2
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT2
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL2
UCB BIOPHARMA2
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS1
ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASTRAZENECA AB1
BARTS AND THE LONDON NHS TRUST1
BAYER1
BAYER PHARMA1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
DRUGS FOR NEGLECTED DISEASES INITIATIVE FONDATION DNDI1
EUROPEAN ALLIANCE FOR PERSONALISED MEDICINE ASBL1
EUROPEAN CANCER PATIENT COALITION1
EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION1
EUROPEAN HEMATOLOGY ASSOCIATION1
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL1
EUROPEAN PATIENTS' FORUM1
EUROPEAN RESEARCH INITIATIVE ON CLL EV1
F HOFFMANNLA ROCHE1
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES1
FOLKEHELSEINSTITUTTET1
FONDAZIONE ITALIANA SINDROMI MIELODISPLASTICHE ETS1
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS1
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON1
FUNDACION HOSPITAL LA FE1
FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON1
GENOME RESEARCH1
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT1
GMV SOLUCIONES GLOBALES INTERNET SAU1
GPOH GEMEINNUTZIGE1
GROUP FOR RESEARCH ON ADULT ACUTE LYMPHOBLASTIC LEUKEMIA1
GROUPE FRANCOPHONE DES MYELODYSPLASIES1
HEALTH IQ LIMITED1
HEINRICHHEINEUNIVERSITAET DUESSELDORF1
IFAKARA HEALTH INSTITUTE TRUST1
IHE INSTITUTET FOR HALSO OCH SJUKVARDSEKONOMI AKTIEBOLAG1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INTERNATIONAL CONSORTIUM FOR HEALTHOUTCOMES MEASUREMENT1
INTERSYSTEMS1
JOHANN WOLFGANG GOETHEUNIVERSITATFRANKFURT AM MAIN1
LEUKANET EV1
LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE1
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN1
MASARYKOVA UNIVERZITA1
MEDISAPIENS OY1
MEDIZINISCHE UNIVERSITAET WIEN1
MENARINI RICERCHE1
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN1
MERCK SHARP & DOHME CORP1
MLL MUNCHNER LEUKAMIELABOR1
MUSEUM NATIONAL D'HISTOIRE NATURELLE1
NOVO NORDISK1
ODYSSEUS DATA SERVICES SRO1
OSPEDALE PEDIATRICO BAMBINO GESU1
SEMMELWEIS EGYETEM1
STATENS LEGEMIDDELVERK1
STICHTING VUMC1
STIFTELSEN WHO COLLABORATING CENTRE FOR INTERNATIONAL DRUG MONITORING1
STIFTUNG ELN FOUNDATION1
SWISS TROPICAL INSTITUTE1
TAKEDA DEVELOPMENT CENTRE EUROPE1
TANDVARDSOCH LAKEMEDELSFORMANSVERKET1
TARTU ULIKOOL1
THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE1
THE EUROPEAN MULTIPLE SCLEROSIS PLATFORM AISBL1
THE HYVE BV1
THE LYMPHOMA STUDY ASSOCIATION1
THE UNIVERSITY OF LIVERPOOL1
TMF TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG EV1
UNIVERSIDAD DE NAVARRA1
UNIVERSIDADE DE AVEIRO1
UNIVERSITA COMMERCIALE LUIGI BOCCONI1
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA1
UNIVERSITA DEGLI STUDI DI TORINO1
UNIVERSITAET ULM1
UNIVERSITATSKLINIKUM BONN1
UNIVERSITY OF BOLOGNA1
UNIVERSITY OF BUEA1
UNIVERSITY OF HELSINKI1
UNIVERSITY OF NEWCASTLE UPON TYNE1
UNIVERSITY OF YORK1
VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV1
VIB VZW1
Constancy:

Total number of partners:115

Partner loyalty:
Frequent Partner: (> 2 projects): 9
Rare Partner: 106

Frequent / Rare Partner Ratio: 0.08

Diversity:

Subjects:
Subject:No:
Diversity index:0
Categories:
Category:No:

Project overview:

Start dateProjectacronymrolefundingpartners
2019-09-01Collaboration for innovation: Establishment of a pan-nematode drug development platform HELPparticipant8.713.3958
2018-11-01European Health Data and Evidence Network EHDENparticipant14.105.75022
2017-02-01Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 DO-ITparticipant3.549.83336
2017-01-01Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 HARMONYparticipant20.200.00053
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum